サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：トランスフォーミング成長因子の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、グレード別、用途別、エンドユーザー別、地域別
市場調査レポート
商品コード
1389785

トランスフォーミング成長因子の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、グレード別、用途別、エンドユーザー別、地域別

Transforming Growth Factor Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

出版日
ページ情報
英文 345 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
トランスフォーミング成長因子の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、グレード別、用途別、エンドユーザー別、地域別
出版日: 2023年11月23日
発行: Fairfield Market Research
ページ情報: 英文 345 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のトランスフォーミング成長因子（TGF）の市場規模は、2024年には3億9,000万米ドルになるとみられ、2031年末には7億4,000万米ドル近くに達する見込みです。

TGF市場の多くの企業が様々な製品とサービスを提供する一方で、GMPグレードの製品と試薬のサプライヤーであることに焦点を当てる動きが活発化しています。この特化したアプローチにより、より高い製品品質と確立された流通網が確保されます。ライフサイエンス業界は、世界でもトップクラスの研究開発費水準を誇っており、今後も投資の拡大が見込まれています。さらに、研究開発や技術への投資が北米や欧州からアジア太平洋、特にインドのような熟練労働力と政府の優遇措置のある国々にシフトしていることも、市場の成長を促進すると予想されます。

ライフサイエンス研究者の複雑化する要求に応えるために、斬新で高コストの製品を開発することは、消費者、特に予算に制約のある研究チームにためらいを与えています。さらに、特定の成長因子には高額な値札がついており、多くの研究室にとって入手が制限されています。研究開発部門における熟練した専門家の不足は、主に低い給与水準、厳しい課題、不十分なトレーニングが原因であり、もう一つの課題となっています。このような経験豊富な人材の不足は、研究施設の制限とともに、世界市場の成長を妨げる可能性があります。

米国市場は2022年に北米市場の約94.1%を占めました。医薬品製造への設備投資の増加と米国内の既存メーカーの増加が市場の売上を牽引しています。個別化医薬品の商業化と新規生物製剤の研究開発強化が、同国市場をさらに押し上げると予想されます。

2022年の欧州市場におけるドイツの市場シェアは約28.2%でした。世界の一人当たりヘルスケアコストの上昇は、ヘルスケア支出に大きな影響を与えています。ドイツには成長因子製品の生産施設があるため、製品の入手性が向上しています。さらに、大手企業は製品ポートフォリオを拡大するためにM&Aを実施しており、市場の成長に寄与しています。

2022年の市場シェアは約46.8%で、中国が東アジア市場を独占しています。中国の経済成長は、CRO（医薬品開発業務受託機関）やCMO（医薬品製造業務受託機関）の急増と相まって、市場の売上を押し上げています。経済、社会、環境の変化がこうした動きに寄与し、同国の成長構造における不均衡が縮小しています。

当レポートでは、世界のトランスフォーミング成長因子市場について調査し、市場の概要とともに、製品別、グレード別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界のトランスフォーミング成長因子市場の見通し、2018年～2031年

  • 世界のトランスフォーミング成長因子市場の見通し、製品別、金額（100万米ドル）、数量（100万個）、2018年～2031年
  • 世界のトランスフォーミング成長因子市場の見通し、グレード別、金額（100万米ドル）、数量（100万個）、2018年～2031年
  • 世界のトランスフォーミング成長因子市場の見通し、用途別、金額（100万米ドル）、数量（100万個）、2018年～2031年
  • 世界のトランスフォーミング成長因子市場の見通し、エンドユーザー別、金額（100万米ドル）、数量（100万個）、2018年～2031年
  • 世界のトランスフォーミング成長因子市場の見通し、地域別、金額（100万米ドル）、数量（100万個）、2018年～2031年

第4章 北米のトランスフォーミング成長因子市場の見通し、2018年～2031年

第5章 欧州のトランスフォーミング成長因子市場の見通し、2018年～2031年

第6章 アジア太平洋のトランスフォーミング成長因子市場の見通し、2018年～2031年

第7章 ラテンアメリカのトランスフォーミング成長因子市場の見通し、2018年～2031年

第8章 中東・アフリカのトランスフォーミング成長因子市場の見通し、2018年～2031年

第9章 競合情勢

  • 用途別とグレード別のヒートマップ
  • メーカーとグレード別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競争力ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific
    • Lonza Group AG
    • Merck KGaA
    • F. Hoffmann-La Roche Ltd
    • Abcam plc.
    • Bio-Techne.
    • Sartorius CellGenix GmbH
    • Proteintech Group, Inc.
    • PeproTech Inc.
    • Cell Signaling Technology, Inc.
    • Meridian Bioscience Inc.
    • Applied Biological Materials (abm), Inc.
    • Akron Biotech
    • Leadgene Biomedical, Inc
    • GE Healthcare

第10章 付録

目次

Fairfield Market Research, a premier market research firm, has unveiled its latest report on the Transforming Growth Factor (TGF) market, projecting a robust growth trajectory. The global revenue for TGF market was recorded at US$ 390 million in 2024, and it is poised to reach valuation of nearly US$ 740 million by the end of 2031.

Fueling Global TGF Market Growth

Specialty Products and Asia Pacific Market Expansion: While many businesses in the TGF market offer a range of products and services, there is a growing focus on being a supplier of GMP-grade products and reagents. This specialized approach ensures higher product quality and a well-established distribution network. The life sciences industry, which boasts one of the highest R&D spending levels globally, is expected to continue increasing its investment. Furthermore, the shift in R&D and technology investments from North America and Europe to Asia Pacific, particularly in countries like India, with its skilled labor force and government incentives, is expected to drive market growth.

Potential Challenges

Lack of Skilled Professionals and High Product Costs: The development of novel, high-cost products to meet the increasingly complex requirements of life sciences researchers has created hesitation among consumers, particularly research teams with budget constraints. Additionally, certain growth factors come with a hefty price tag, limiting access for many laboratories. A shortage of skilled professionals in the research and development sector, primarily due to low pay scales, demanding duties, and insufficient training, poses another challenge. This shortage of experienced individuals, along with limitations in research facilities, may hamper global market growth.

Country-wise Insights

Booming U.S. Market: The U.S. market accounted for approximately 94.1% of the North America market in 2022. Increasing capital expenditure on pharmaceutical manufacturing and a growing number of established manufacturers within the U.S. have driven market sales. The commercialization of personalized pharmaceutical products and intensified research and development efforts in novel biologics are expected to further boost the market in the country.

Lucrative German Market: Germany held about 28.2% market share in the Europe market in 2022. The rising cost of healthcare per capita globally has significantly affected healthcare spending. The presence of production facilities for growth factor products in Germany has improved product availability. Moreover, major companies are engaging in mergers and acquisitions to expand their product portfolios, contributing to market growth.

Emerging Chinese Market: China dominated the East Asia market with a market share of approximately 46.8% in 2022. China's growing economy, coupled with a surge in Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) activities, has propelled market sales. Economic, social, and environmental shifts have contributed to these developments, reducing imbalances in the country's growth structure.

Competitive Landscape

Market players are employing strategies such as acquisitions, mergers, expansions, and product launches to enhance their market presence. Asia Pacific is witnessing significant Research and Development (R&D) investments by corporations aiming to diversify their product offerings and capture market share in emerging economies.

Key Market Players

  • Thermo Fisher Scientific
  • Lonza Group AG
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Abcam plc.
  • Bio-Techne.
  • Sartorius CellGenix GmbH
  • Proteintech Group, Inc.
  • PeproTech Inc.
  • Cell Signaling Technology, Inc.
  • Meridian Bioscience Inc.
  • Applied Biological Materials (abm), Inc.
  • Akron Biotech
  • Leadgene Biomedical, Inc
  • GE Healthcare

Key Segments Covered in Transforming Growth Factor Industry Research

Product:

  • Activin
  • Bone Morphogenetic Proteins (BMPs)
  • TGF-beta Proteins

Grade:

  • GMP Grade
  • Non-GMP Grade

Application:

  • Oncology Research
  • Hematology Research
  • Wound Healing Research
  • Dermatology Research
  • Cardiovascular Disease & Diabetes
  • Cell Therapy and Ex vivo Manufacturing
  • Others

End User:

  • Pharmaceutical and Biotechnology Companies
  • Research Centers & Academic Institutes
  • CMO and CDMO

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Transforming Growth Factor Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Transforming Growth Factor Market Outlook, 2018 - 2031

  • 3.1. Global Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Activin
      • 3.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 3.1.1.3. TGF-beta Proteins
  • 3.2. Global Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. GMP Grade
      • 3.2.1.2. Non-GMP Grade
  • 3.3. Global Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oncology Research
      • 3.3.1.2. Hematology Research
      • 3.3.1.3. Wound Healing Research
      • 3.3.1.4. Dermatology Research
      • 3.3.1.5. Cardiovascular Disease & Diabetes
      • 3.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 3.3.1.7. Others
  • 3.4. Global Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Pharmaceutical and Biotechnology Companies
      • 3.4.1.2. Research Centers & Academic Institutes
      • 3.4.1.3. CMO and CDMO
  • 3.5. Global Transforming Growth Factor Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Transforming Growth Factor Market Outlook, 2018 - 2031

  • 4.1. North America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Activin
      • 4.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 4.1.1.3. TGF-beta Proteins
  • 4.2. North America Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. GMP Grade
      • 4.2.1.2. Non-GMP Grade
  • 4.3. North America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oncology Research
      • 4.3.1.2. Hematology Research
      • 4.3.1.3. Wound Healing Research
      • 4.3.1.4. Dermatology Research
      • 4.3.1.5. Cardiovascular Disease & Diabetes
      • 4.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 4.3.1.7. Others
  • 4.4. North America Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Pharmaceutical and Biotechnology Companies
      • 4.4.1.2. Research Centers & Academic Institutes
      • 4.4.1.3. CMO and CDMO
  • 4.5. North America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.2. U.S. Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.3. U.S. Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031 by End User
      • 4.5.1.4. U.S. Transforming Growth Factor Market, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.5. Canada Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.6. Canada Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.7. Canada Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.8. Canada Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Transforming Growth Factor Market Outlook, 2018 - 2031

  • 5.1. Europe Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Activin
      • 5.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 5.1.1.3. TGF-beta Proteins
  • 5.2. Europe Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. GMP Grade
      • 5.2.1.2. Non-GMP Grade
  • 5.3. Europe Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oncology Research
      • 5.3.1.2. Hematology Research
      • 5.3.1.3. Wound Healing Research
      • 5.3.1.4. Dermatology Research
      • 5.3.1.5. Cardiovascular Disease & Diabetes
      • 5.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 5.3.1.7. Others
  • 5.4. Europe Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Pharmaceutical and Biotechnology Companies
      • 5.4.1.2. Research Centers & Academic Institutes
      • 5.4.1.3. CMO and CDMO
  • 5.5. Europe Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.2. Germany Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.3. Germany Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.4. Germany Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.5. U.K. Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.6. U.K. Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.7. U.K. Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.8. U.K. Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.9. France Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.10. France Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.11. France Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.12. France Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.13. Italy Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.14. Italy Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.15. Italy Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.16. Italy Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.17. Turkey Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.18. Turkey Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.19. Turkey Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.20. Turkey Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.21. Russia Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.22. Russia Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.23. Russia Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.24. Russia Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.25. Rest of Europe Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.26. Rest of Europe Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.27. Rest of Europe Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.28. Rest of Europe Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Transforming Growth Factor Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Activin
      • 6.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 6.1.1.3. TGF-beta Proteins
  • 6.2. Asia Pacific Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. GMP Grade
      • 6.2.1.2. Non-GMP Grade
  • 6.3. Asia Pacific Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oncology Research
      • 6.3.1.2. Hematology Research
      • 6.3.1.3. Wound Healing Research
      • 6.3.1.4. Dermatology Research
      • 6.3.1.5. Cardiovascular Disease & Diabetes
      • 6.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 6.3.1.7. Others
  • 6.4. Asia Pacific Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Pharmaceutical and Biotechnology Companies
      • 6.4.1.2. Research Centers & Academic Institutes
      • 6.4.1.3. CMO and CDMO
  • 6.5. Asia Pacific Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.2. China Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.3. China Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.4. China Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.5. Japan Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.6. Japan Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.7. Japan Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.8. Japan Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.9. South Korea Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.10. South Korea Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.11. South Korea Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.12. South Korea Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.13. India Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.14. India Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.15. India Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.16. India Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.17. Southeast Asia Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.18. Southeast Asia Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.19. Southeast Asia Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.20. Southeast Asia Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Transforming Growth Factor Market Outlook, 2018 - 2031

  • 7.1. Latin America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Activin
      • 7.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 7.1.1.3. TGF-beta Proteins
  • 7.2. Latin America Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.1. GMP Grade
      • 7.2.1.2. Non-GMP Grade
  • 7.3. Latin America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oncology Research
      • 7.3.1.2. Hematology Research
      • 7.3.1.3. Wound Healing Research
      • 7.3.1.4. Dermatology Research
      • 7.3.1.5. Cardiovascular Disease & Diabetes
      • 7.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 7.3.1.7. Others
  • 7.4. Latin America Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Pharmaceutical and Biotechnology Companies
      • 7.4.1.2. Research Centers & Academic Institutes
      • 7.4.1.3. CMO and CDMO
  • 7.5. Latin America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.2. Brazil Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.3. Brazil Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.4. Brazil Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.5. Mexico Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.6. Mexico Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.7. Mexico Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.8. Mexico Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.9. Argentina Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.10. Argentina Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.11. Argentina Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.12. Argentina Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Transforming Growth Factor Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Activin
      • 8.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 8.1.1.3. TGF-beta Proteins
  • 8.2. Middle East & Africa Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. GMP Grade
      • 8.2.1.2. Non-GMP Grade
  • 8.3. Middle East & Africa Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oncology Research
      • 8.3.1.2. Hematology Research
      • 8.3.1.3. Wound Healing Research
      • 8.3.1.4. Dermatology Research
      • 8.3.1.5. Cardiovascular Disease & Diabetes
      • 8.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 8.3.1.7. Others
  • 8.4. Middle East & Africa Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Pharmaceutical and Biotechnology Companies
      • 8.4.1.2. Research Centers & Academic Institutes
      • 8.4.1.3. CMO and CDMO
  • 8.5. Middle East & Africa Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.2. GCC Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.3. GCC Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.4. GCC Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.5. South Africa Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.6. South Africa Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.7. South Africa Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.8. South Africa Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.9. Egypt Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.10. Egypt Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.11. Egypt Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.12. Egypt Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.13. Nigeria Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.14. Nigeria Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.15. Nigeria Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.16. Nigeria Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. by Application vs by Grade Heatmap
  • 9.2. Manufacturer vs by Grade Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Thermo Fisher Scientific
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Lonza Group AG
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Merck KGaA
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. F. Hoffmann-La Roche Ltd
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Abcam plc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Bio-Techne.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Sartorius CellGenix GmbH
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Proteintech Group, Inc.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. PeproTech Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Cell Signaling Technology, Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Meridian Bioscience Inc.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Applied Biological Materials (abm), Inc.
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Akron Biotech
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Leadgene Biomedical, Inc
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. GE Healthcare
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations